Remifentanil at induction of general anesthesia for cesarean section: Double blind, randomized clinical trial;Remifentanilo en la inducción de la anestesia general para la cesárea: Estudio clínico doble ciego, ensayo clínico aleatorizado

Colombia Medica

Volumn 44, Issue 2, 2013, Pages 87-91

  Behdad, Shekoufeh ^a   Ayatollahi, Vida ^a   Harrazi, Hamid ^b   Nazemian, Nadrali ^a   Heiranizadeh, Najmeh ^a   Behnam, Baghianimoghadam ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Shohaday e Kargar Hospital   (Iran)

Author keywords

Caesarean; Placebo; Remifentanil

Indexed keywords

FENTANYL; METOCLOPRAMIDE; PLACEBO; REMIFENTANIL; SUXAMETHONIUM; THIOPENTAL;

ADULT; APGAR SCORE; ARTERIAL PH; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ENDOTRACHEAL INTUBATION; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HEMODYNAMIC PARAMETERS; HUMAN; LARYNGOSCOPY; NEWBORN; OBSTETRIC ANESTHESIA; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SKIN INCISION; SYSTOLIC BLOOD PRESSURE;

EID: 84878590427     PISSN: 01208322     EISSN: 16579534     Source Type: Journal    
DOI: 10.25100/cm.v44i2.1213     Document Type: Article

References (20)

1. Jenkins JG, Khan MM. Anaesthesia for Caesarean section: a survey in a UK region from 1992 to 2002. Anaesthesia 2003; 58:1114-8.
2. Kan RE, Hughes SC, Rosen MA, Kessin C, Preston PG, Lobo EP. Intravenous remifentanil: placental transfer, maternal and neonatal effects. Anesthesiology 1998; 88(6):1467-74.
3. Ngan Kee WD, Khaw KS, Ma KC, Wong AS, Lee BB, Ng FF. Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery: a randomized, double-blind, controlled trial. Anesthesiol 2006;104(1):14-20.
4. Prakash N, McLeod T, Gao Smith F. The effects of remifentanil on haemodynamic stability during rigid bronchoscopy. Anaesthesia 2001;568(6): 576-80.
5. Orme RM, Grange CS, Ainsworth QP, Grebenik CR. General anaesthesia using remifentanil for caesarean section in parturients with critical aortic stenosis: a series of four cases. Int J Obstet Anesth 2004;13(3):183-7.
6. Macfarlane AJ, Moise S, Smith D. Caesarean section using total intravenous anaesthesia in a patient with Ebstein's anomaly complicated by supraventricular tachycardia. Int J Obstet Anesth 2007;16(2): 155-9.
7. Amini S, Yaghmaei M. The use of remifentanil in general anesthesia for cesarean section in a parturient with severe mitral stenosis and pulmonary edema. Middle East J Anesthesiol 2010;20(4):585-8.
8. Bilehjani E, Kianfar AA, Toofan M, Fakhari S. Anesthesia with etomidate and remifentanil for cesarean section in a patient with severe peripartum cardiomyopathy--a case report. Middle East J Anesthesiol 2008;19(5):1141-9.
9. Miyawaki Y, Yumiba T, Asaga T, Taie S, Shirakami G. Remifentanil is useful for cardiovascular stability during cesarean delivery in a parturient with Marfan's syndrome. Masui 2010;59(10):1305-7.
10. Imarengiaye C, Littleford J, Davies S, Thapar K, Kingdom J. Goal oriented general anesthesia for Cesarean section in a parturient with a large intracranial epidermoid cyst. Can J Anaesth 2001;48(9): 884-9.
11. Richa F, Yazigi A, Nasser E, Dagher C, Antakly MC. General anesthesia with remifentanil for Cesarean section in a patient with HELLP syndrome. Acta Anaesthesiol Scand 2005;49(5): 418-20.
12. Carvalho B, Mirikitani EJ, Lyell D, Evans DA, Druzin M, Riley ET. Neonatal chest wall rigidity following the use of remifentanil for cesarean delivery in a patient with autoimmune hepatitis and thrombocytopenia. Int J Obstet Anesth 2004;13(1): 53-6.
13. Draisci G, Valente A, Suppa E, Frassanito L, Pinto R, Meo F, et al. Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal wellbeing: a randomized trial. Int J Obstet Anesth 2008;17(2):130-6.
14. Yoo KY, Jeong CW, Park BY, Kim SJ, Jeong ST, Shin MH, et al. Effects of remifentanil on cardiovascular and bispectral index responses to endotracheal intubation in severe pre-eclamptic patients undergoing Caesarean delivery under general anaesthesia. Br J Anaesth 2009;102(6):812-9.
15. Van de Velde M, Teunkens A, Kuypers M, Dewinter T, Vandermeersch E. General anaesthesia with target controlled infusion of propofol for planned caesarean section: maternal and neonatal effects of a remifentanil-based technique. Int J Obstet Anesth 2004;13(3):153-8.
16. Volmanen P, Akural EI, Raudaskoski T, Alahuhta S. Remifentanil in obstetric analgesia: a dose-finding study. Anesth Analg 2002; 94(4): 913-7.
17. Glass PSA, Hardman D, kamiyama Y, Quil TJ, Marton G, Donn KH, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil. Anesth Analg 1993;77(5): 1031-40.
18. Minto CF, Schnider TW, Short TG, Gregg KM, Gentilini A, Shafer SL. Response surface model for anesthetic drug interactions. Anesthesiology 2000;92(6): 1603-16.
19. McCarroll CP, Paxton LD, Elliott P, Wilson DB. Use of remifentanil in a patient with peripartum cardiomyopathy requiring Caesarean section. Br J Anaesth 2001;86(1):135-8.
20. S ykes GS, Johnson P, Ashworth F, Molloy PM, Gu W, Stirrat GM, et al. Do Apgar scores indicate asphyxia? Lancet 1982; 1(8270): 494-946.